NF-κB is a family of transcription factors which has been shown to be constitutively active in CLL, typically leading to the transcriptional activation of cell survival and proliferation genes which contribute to disease progression as well as therapeutic resistance [3, 4]. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.